Suffolk Capital Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | $10.7M | Buy |
111,908
+18,908
| +20% | +$1.81M | 2.06% | 12 |
|
|
2018
Q3 | $13.1M | Buy |
93,000
+17,536
| +23% | +$2.48M | 1.87% | 21 |
|
|
2018
Q2 | $11.8M | Buy |
75,464
+20,609
| +38% | +$3.23M | 1.68% | 34 |
|
|
2018
Q1 | $8.84M | Sell |
54,855
-8,321
| -13% | -$1.34M | 1.25% | 39 |
|
|
2017
Q4 | $10.4M | Buy |
63,176
+47,665
| +307% | +$7.85M | 1.35% | 37 |
|
|
2017
Q3 | $966K | Sell |
15,511
-4,823
| -24% | -$300K | 0.13% | 103 |
|
|
2017
Q2 | $1.62M | Sell |
20,334
-3,570
| -15% | -$284K | 0.21% | 80 |
|
|
2017
Q1 | $1.7M | Buy |
23,904
+4,500
| +23% | +$320K | 0.23% | 61 |
|
|
2016
Q4 | $991K | Buy |
+19,404
| New | +$991K | 0.14% | 121 |
|